COVID-19
Conditions
Interventions
None listed
Sponsors
Nakashima Kei
Hirota Yoshio
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Any of the following a or b a Patients with lung cancer on chemotherapy over 50 years b Patients with underlying disease (except for cancer) over 50 years old 2) Those who are visiting a medical institution conducting research (Kameda Medical Center, Chikamori hospital) 3) Subjects who voluntarily recieve the COVID-19 vaccine 4) Written informed consent
Exclusion criteria
Exclusion criteria: 1) Those who have the contraindications for vaccination 2) Those who have been vaccinated with the new coronavirus vaccine in the past (Including participation in clinical trials or clinical trials / research) 3) Those who are receiving systemic steroids / immunosuppressants (excluding administration of anticancer drugs as antiemetics) 4) Persons with autoimmune disease under treatment 5) Those who have experienced an acute illness that requires antibiotics or steroids within the past one month 6) Those who have a fever at the time of vaccination, those who present with acute serious illness 7) Persons who are judged by the principal investigator or the investigator to be inappropriate as research subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| immunogenicity | — |
Secondary
| Measure | Time frame |
|---|---|
| effectiveness, side efects after vaccination, vaccine associated adverse events | — |
Contacts
Public ContactKei Nakashima
Kameda Medical Center
Outcome results
None listed